In the BioHarmony Drug Report Database

"Preview" Icon

Travoprost

Izba, Travatan, Travatan Z (travoprost) is a small molecule pharmaceutical. Travoprost was first approved as Izba on 2001-03-16. It is used to treat open-angle glaucoma in the USA. It has been approved in Europe to treat ocular hypertension and open-angle glaucoma. Travatan z’s patents are valid until 2029-10-13 (FDA).

 

Trade Name

 

Izba, Travatan
 

Common Name

 

travoprost
 

ChEMBL ID

 

CHEMBL1200799
 

Indication

 

ocular hypertension, open-angle glaucoma
 

Drug Class

 

Prostaglandins

Image (chem structure or protein)

Travoprost structure rendering